Emmaus Life Sciences Inc (EMMA)
0.0921
-0.02
(-19.03%)
USD |
OTCM |
Apr 19, 09:37
Emmaus Life Sciences Market Cap: 4.940M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 6.101M |
| April 17, 2024 | 6.101M |
| April 16, 2024 | 6.101M |
| April 15, 2024 | 5.632M |
| April 12, 2024 | 5.632M |
| April 11, 2024 | 5.632M |
| April 10, 2024 | 5.632M |
| April 09, 2024 | 5.632M |
| April 08, 2024 | 5.632M |
| April 05, 2024 | 5.967M |
| April 04, 2024 | 5.632M |
| April 03, 2024 | 5.632M |
| April 02, 2024 | 5.632M |
| April 01, 2024 | 6.101M |
| March 28, 2024 | 5.632M |
| March 27, 2024 | 6.276M |
| March 26, 2024 | 4.827M |
| March 25, 2024 | 4.827M |
| March 22, 2024 | 5.525M |
| March 21, 2024 | 6.866M |
| March 20, 2024 | 4.827M |
| March 19, 2024 | 4.594M |
| March 18, 2024 | 5.423M |
| March 15, 2024 | 5.423M |
| March 14, 2024 | 6.168M |
| Date | Value |
|---|---|
| March 13, 2024 | 6.168M |
| March 12, 2024 | 5.986M |
| March 11, 2024 | 5.908M |
| March 08, 2024 | 5.830M |
| March 07, 2024 | 5.986M |
| March 06, 2024 | 6.144M |
| March 05, 2024 | 5.417M |
| March 04, 2024 | 5.900M |
| March 01, 2024 | 6.812M |
| February 29, 2024 | 6.363M |
| February 28, 2024 | 6.504M |
| February 27, 2024 | 6.968M |
| February 26, 2024 | 6.973M |
| February 23, 2024 | 5.900M |
| February 22, 2024 | 7.088M |
| February 21, 2024 | 4.666M |
| February 20, 2024 | 4.666M |
| February 16, 2024 | 4.666M |
| February 15, 2024 | 5.155M |
| February 14, 2024 | 5.155M |
| February 13, 2024 | 5.155M |
| February 12, 2024 | 5.578M |
| February 09, 2024 | 5.364M |
| February 08, 2024 | 5.015M |
| February 07, 2024 | 5.793M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
3.958M
Minimum
Jan 09 2024
465.16M
Maximum
Jul 18 2019
52.03M
Average
53.32M
Median
Feb 04 2020
Market Cap Benchmarks
| AIM ImmunoTech Inc | 23.50M |
| Perspective Therapeutics Inc | 877.44M |
| Protalix BioTherapeutics Inc | 84.38M |
| Electromed Inc | 126.75M |
| Armata Pharmaceuticals Inc | 90.37M |
Market Cap Related Metrics
| PS Ratio | 0.2359 |
| Price | 0.0921 |
| Earnings Yield | -97.19% |
| Operating PE Ratio | 8.752 |